» Authors » Claire Beraud

Claire Beraud

Explore the profile of Claire Beraud including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 147
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Len-Tayon K, Beraud C, Fauveau C, Belorusova A, Chebaro Y, Mourino A, et al.
Br J Pharmacol . 2024 Jul; 181(21):4279-4293. PMID: 38982588
Background And Purpose: Castration-resistant prostate cancer (CRPC) is a common male malignancy that requires new therapeutic strategies due to acquired resistance to its first-line treatment, docetaxel. The benefits of vitamin...
2.
Beraud C, Bidan N, Lassalle M, Lang H, Lindner V, Krucker C, et al.
Front Oncol . 2023 Jun; 13:1130048. PMID: 37305585
Background: Despite the significant advances in the management of advanced prostate cancer (PCa), metastatic PCa is currently considered incurable. For further investigations in precision treatment, the development of preclinical models...
3.
Lang H, Beraud C, Cabel L, Fontugne J, Lassalle M, Krucker C, et al.
Front Oncol . 2022 Aug; 12:930731. PMID: 36033544
Background: Muscle-invasive bladder cancer (MIBC) and upper urinary tract urothelial carcinoma (UTUC) are molecularly heterogeneous. Despite chemotherapies, immunotherapies, or anti-fibroblast growth factor receptor (FGFR) treatments, these tumors are still of...
4.
Rochel N, Krucker C, Coutos-Thevenot L, Osz J, Zhang R, Guyon E, et al.
Nat Commun . 2019 Jan; 10(1):253. PMID: 30651555
The upregulation of PPARγ/RXRα transcriptional activity has emerged as a key event in luminal bladder tumors. It renders tumor cell growth PPARγ-dependent and modulates the tumor microenvironment to favor escape...
5.
Hamaidi I, Coquard C, Danilin S, Dormoy V, Beraud C, Rothhut S, et al.
Oncogene . 2018 Aug; 38(1):60-72. PMID: 30076415
Metastatic clear cell renal cell carcinoma (CCC) remains incurable despite advances in the development of anti-angiogenic targeted therapies and the emergence of immune checkpoint inhibitors. We have previously shown that...
6.
Mahe M, Dufour F, Neyret-Kahn H, Moreno-Vega A, Beraud C, Shi M, et al.
EMBO Mol Med . 2018 Feb; 10(4). PMID: 29463565
FGFR3 alterations (mutations or translocation) are among the most frequent genetic events in bladder carcinoma. They lead to an aberrant activation of FGFR3 signaling, conferring an oncogenic dependence, which we...
7.
Hochane M, Raison D, Coquard C, Beraud C, Danilin S, Bethry A, et al.
Am J Pathol . 2018 Jan; 188(4):863-875. PMID: 29353060
Proliferative glomerulonephritis is characterized by local inflammation and mesangial cell deterioration, followed by mesangial proliferation and glomerular healing. Parathyroid hormone-related peptide (PTHrP) is a mesangial cytokine-like growth factor implicated in...
8.
Hochane M, Raison D, Coquard C, Beraud C, Bethry A, Danilin S, et al.
Am J Physiol Cell Physiol . 2017 Nov; 314(2):C242-C253. PMID: 29141920
Injury of mesangial cells (MC) is a prominent feature of glomerulonephritis. Activated MC secrete inflammatory mediators that induce cell apoptosis. Parathyroid hormone-related peptide (PTHrP) is a locally active cytokine that...
9.
Lang H, Beraud C, Bethry A, Danilin S, Lindner V, Coquard C, et al.
Oncotarget . 2016 Jul; 7(37):59336-59359. PMID: 27449081
The objective of the present work was to establish a large panel of preclinical models of human renal cell carcinoma (RCC) directly from patients, faithfully reproducing the biological features of...
10.
Beraud C, Dormoy V, Danilin S, Lindner V, Bethry A, Hochane M, et al.
Int J Cancer . 2015 Mar; 137(7):1549-59. PMID: 25809490
Human conventional renal cell carcinoma (CCC) remains resistant to current therapies. Focal Adhesion Kinase (FAK) is upregulated in many epithelial tumors and clearly implicated in nearly all facets of cancer....